Progyny IPO
Progyny is a leading fertility benefits management company that partners with employers to provide comprehensive fertility and family building benefits to their employees. The company manages fertility benefits including IVF, egg freezing, and other reproductive treatments through its network of high-quality providers. Investors value Progyny's position in the growing employer benefits market and its focus on improving outcomes while managing costs in fertility care.
Key Facts
| Industry | Digital Health |
| Founded | 2008 |
| Headquarters | New York, NY |
| Employees | ~1,000 |
| Website | progyny.com |
| Funding | Public company since 2019 IPO |
About Progyny
Progyny is a leading benefits management company specializing in fertility and family building benefits. The company provides comprehensive fertility solutions including coverage for IVF, egg freezing, adoption, surrogacy, and other reproductive health services through employer-sponsored benefits programs. Progyny's unique model combines medical expertise with technology to help employees navigate complex fertility treatments while managing costs for employers. The company went public in 2019 and has established itself as a major player in the rapidly growing fertility benefits market, serving millions of members across hundreds of enterprise clients. Their platform includes a patient advocacy program, provider network management, and data analytics to optimize outcomes and costs in fertility care.
IPO Status
Progyny went public in October 2019, pricing its IPO at $13 per share and raising approximately $130 million. The company's public debut was well-received by investors, reflecting strong interest in the fertility benefits management market and Progyny's leading position in the space. Since going public, Progyny has continued to grow its client base and expand its network of fertility providers. The stock has generally performed well as the company has demonstrated consistent revenue growth and benefited from increased employer focus on comprehensive fertility benefits. Progyny trades on the NASDAQ under the ticker symbol PGNY.
Competitors
Frequently Asked Questions
Does Progyny have a stock?
Yes, Progyny completed its IPO in October 2019 and is publicly traded. The fertility benefits company has been public for several years and trades on the NASDAQ.
When is the Progyny IPO date?
Progyny's IPO took place in October 2019 when the company went public at $13 per share. The IPO has already occurred and was completed successfully.
How can I buy Progyny stock?
You can buy Progyny stock through any brokerage account as it trades publicly on the NASDAQ under the ticker symbol PGNY. The stock is available for purchase during regular market hours through most brokers.
Don't Miss the Next Big IPO
Get notified when the next major company files for an IPO. Daily alerts delivered to your inbox.
Get IPO Alerts